Tag: commercialization
UofL research projects land KYNETIC grants
The Kentucky Network for Innovation and Commercialization (KYNETIC) has selected eight applicants from its Cycle 6 for project funding.
KYNETIC is a National Institutes of Health (NIH)...
UofL secures record-breaking $201.5 million in powerhouse year for research Funding...
The University of Louisville secured a record $201.5 million in the 2021 fiscal year to support groundbreaking research.
That funding, an increase of more than...
UofL-born cell therapy startup completes $150 million IPO
A University of Louisville startup working to develop a therapy that could improve the lives of kidney transplant recipients and sufferers of severe autoimmune...
UofL student cancer tech startup wins inaugural innovation competitionÂ
A University of Louisville student startup aimed at fighting cancer has won the inaugural CardStart innovation competition.Â
The startup is MAC-BIO, led by MD/PhD student...
UofL receives grant to launch COVID-19 tech accelerator University seeks ideas...
The University of Louisville has received $750,000 from the U.S. Economic Development Administration to launch a new program aimed at solving the long-term health,...
UofL heart technology goes head-to-head with other innovations in bracket competition
A University of Louisville technology that could give researchers a longer window to test new medicines on human tissue samples is going head-to-head with...
UofL researcher uses fruit for less toxic drug delivery Suite of...
UofL researchers have found a less toxic way to deliver medicines by using the natural lipids in plants, particularly grapefruit and ginger.
The resulting intellectual...
UofL secures $170 million in record-breaking year for research Funding from...
The University of Louisville secured nearly $170 million to support groundbreaking research in the 2019-2020 fiscal year — the university’s most successful year ever...
UofL-born cell therapy for organ transplants enters Phase 3 trial First...
A cell therapy born at the University of Louisville that could improve the lives of kidney transplant recipients has entered its Phase 3 clinical...
UofL-born technology for treating Type 1 diabetes has commercial partner
A University of Louisville-born therapy that helps people with Type 1 diabetes stay off immunosuppressants by re-educating the body’s immune system to accept transplanted...































